Report Overview: The Global Creatinine Test Market achieved a valuation of $1154.20 Million in 2022 and is anticipated to exceed $3783.92 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 16% during the forecast period from 2024 to 2032. Key Market Players: BioAssay Systems, Abcam plc, Arbor Assays, Thermo Fisher Scientific, Randox Laboratories Ltd.,...